Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Basic Science Article
  • Published:

Extracorporeal life support without systemic anticoagulation: a nitric oxide-based non-thrombogenic circuit for the artificial placenta in an ovine model

Abstract

Background

Clinical translation of the extracorporeal artificial placenta (AP) is impeded by the high risk for intracranial hemorrhage in extremely premature newborns. The Nitric Oxide Surface Anticoagulation (NOSA) system is a novel non-thrombogenic extracorporeal circuit. This study aims to test the NOSA system in the AP without systemic anticoagulation.

Methods

Ten extremely premature lambs were delivered and connected to the AP. For the NOSA group, the circuit was coated with DBHD-N2O2/argatroban, 100 ppm nitric oxide was blended into the sweep gas, and no systemic anticoagulation was given. For the Heparin control group, a non-coated circuit was used and systemic anticoagulation was administered.

Results

Animals survived 6.8 ± 0.6 days with normal hemodynamics and gas exchange. Neither group had any hemorrhagic or thrombotic complications. ACT (194 ± 53 vs. 261 ± 86 s; p < 0.001) and aPTT (39 ± 7 vs. 69 ± 23 s; p < 0.001) were significantly lower in the NOSA group than the Heparin group. Platelet and leukocyte activation did not differ significantly from baseline in the NOSA group. Methemoglobin was 3.2 ± 1.1% in the NOSA group compared to 1.6 ± 0.6% in the Heparin group (p < 0.001).

Conclusions

The AP with the NOSA system successfully supported extremely premature lambs for 7 days without significant bleeding or thrombosis.

Impact

  • The Nitric Oxide Surface Anticoagulation (NOSA) system provides effective circuit-based anticoagulation in a fetal sheep model of the extracorporeal artificial placenta (AP) for 7 days.

  • The NOSA system is the first non-thrombogenic circuit to consistently obviate the need for systemic anticoagulation in an extracorporeal circuit for up to 7 days.

  • The NOSA system may allow the AP to be implemented clinically without systemic anticoagulation, thus greatly reducing the intracranial hemorrhage risk for extremely low gestational age newborns.

  • The NOSA system could potentially be applied to any form of extracorporeal life support to reduce or avoid systemic anticoagulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Artificial placenta (AP) circuit.
Fig. 2: Circuit and oxygenator performance.
Fig. 3: Coagulation profile.
Fig. 4: Platelets.
Fig. 5: Leukocytes.
Fig. 6: NOSA circuit after 7 days of AP support.

Similar content being viewed by others

Data availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Stoll, B. J. et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126, 443–456 (2010).

    Article  PubMed  Google Scholar 

  2. Church, J. T. et al. Pushing the boundaries of ECLS: outcomes in <34 week EGA neonates. J. Pediatr. Surg. 52, 1810–1815 (2017).

    Article  PubMed  Google Scholar 

  3. Church, J. T. et al. The artificial placenta: continued lung development during extracorporeal support in a preterm lamb model. J. Pediatr. Surg. 53, 1896–1903 (2018).

  4. Church, J. T. et al. Perfluorocarbons prevent lung injury and promote development during artificial placenta support in extremely premature lambs. Neonatology 113, 313–321 (2018).

    Article  CAS  PubMed  Google Scholar 

  5. Church, J. T. et al. Effects of an artificial placenta on brain development and injury in premature lambs. J. Pediatr. Surg. 53, 1234–1239 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Coughlin, M. A. et al. An artificial placenta protects against lung injury and promotes continued lung development in extremely premature lambs. ASAIO J. 65, 690–697 (2019).

  7. El-Sabbagh, A. M. et al. Cerebral oxygenation of premature lambs supported by an artificial placenta. ASAIO J. 64, 552–556 (2018).

  8. McLeod, J. S. et al. Splenic development and injury in premature lambs supported by the artificial placenta. J. Pediatr. Surg. 54, 1147–1152 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  9. McLeod, J. S. et al. Gastrointestinal mucosal development and injury in premature lambs supported by the artificial placenta. J. Pediatr. Surg. 53, 1240–1245 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Nasr, V. G. et al. Highlights from the Extracorporeal Life Support Organization Registry: 2006–2017. ASAIO J. 65, 537–544 (2019).

    Article  PubMed  Google Scholar 

  11. Hardart, G. E., Hardart, M. K. M. & Arnold, J. H. Intracranial hemorrhage in premature neonates treated with extracorporeal membrane oxygenation correlates with conceptional age. J. Pediatr. 145, 184–189 (2004).

    Article  PubMed  Google Scholar 

  12. Fallon, B. P. et al. A pumpless artificial lung without systemic anticoagulation: the Nitric Oxide Surface Anticoagulation system. J. Pediatr. Surg. 57, 26–33 (2022).

  13. Major, T. C. et al. The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation. Biomaterials 35, 7271–7285 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Handa, H. et al. In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-doped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive. J. Mater. Chem. B 1, 3578 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Batchelor, M. M. et al. More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 46, 5153–5161 (2003).

    Article  CAS  PubMed  Google Scholar 

  16. Qin, Y. et al. Portable nitric oxide (NO) generator based on electrochemical reduction of nitrite for potential applications in inhaled no therapy and cardiopulmonary bypass surgery. Mol. Pharm. 14, 3762–3771 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bryner, B. et al. An extracorporeal artificial placenta supports extremely premature lambs for 1 week. J. Pediatr. Surg. 50, 44–49 (2015).

    Article  PubMed  Google Scholar 

  18. Major, T. C. et al. The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer. Biomaterials 31, 2736–2745 (2010).

    Article  CAS  PubMed  Google Scholar 

  19. El-Sabbagh, A. M. et al. Effect of air exposure and suction on blood cell activation and hemolysis in an in vitro cardiotomy suction model. ASAIO J. 59, 474–479 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  20. Harvey, S. L. et al. Hepatic function in premature lambs supported by the artificial placenta and total parenteral nutrition. ASAIO J. 68, 949–955 (2022).

  21. Korn, R. L. et al. The effects of carmeda bioactive surface on human blood components during simulated extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 111, 1073–1084 (1996).

    Article  CAS  PubMed  Google Scholar 

  22. Willers, A. et al. New trends, advantages and disadvantages in anticoagulation and coating methods used in extracorporeal life support devices. Membranes 11, 617 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wang, Y.-B., Shi, K.-H., Jiang, H.-L. & Gong, Y.-K. Significantly reduced adsorption and activation of blood components in a membrane oxygenator system coated with crosslinkable Zwitterionic copolymer. Acta Biomater. 40, 153–161 (2016).

    Article  CAS  PubMed  Google Scholar 

  24. Tanaka, M. et al. Blood compatible aspects of poly (2-methoxyethylacrylate)(PMEA)—relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 21, 1471–1481 (2000).

    Article  CAS  PubMed  Google Scholar 

  25. Wendel, H. P. & Ziemer, G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur. J. Cardiothorac. Surg. 16, 342–350 (1999).

    Article  CAS  PubMed  Google Scholar 

  26. Biran, R. & Pond, D. Heparin coatings for improving blood compatibility of medical devices. Adv. Drug Deliv. Rev. 112, 12–23 (2017).

    Article  CAS  PubMed  Google Scholar 

  27. Roberts, T. R. et al. Tethered liquid perfluorocarbon coating for 72 h heparin-free extracorporeal life support. ASAIO J. 67, 798–808 (2021).

  28. Ukita, R. et al. Zwitterionic poly-carboxybetaine coating reduces artificial lung thrombosis in sheep and rabbits. Acta Biomater. 92, 71–81 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Klein, S. et al. Endoxy: dynamic long-term evaluation of endothelialized gas exchange membranes for a biohybrid lung. Ann. Biomed. Eng. 48, 747–756 (2020).

    Article  PubMed  Google Scholar 

  30. Wo, Y., Brisbois, E. J., Bartlett, R. H. & Meyerhoff, M. E. Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO). Biomater. Sci. 4, 1161–1183 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Major, T. C. et al. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model. Biomaterials 32, 5957–5969 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Robinson, T. M., Kickler, T. S., Walker, L. K., Ness, P. & Bell, W. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit. Care Med. 21, 1029–1034 (1993).

    Article  CAS  PubMed  Google Scholar 

  33. Cortazzo, J. A. & Lichtman, A. D. Methemoglobinemia: a review and recommendations for management. J. Cardiothorac. Vasc. Anesth. 28, 1043–1047 (2014).

    Article  CAS  PubMed  Google Scholar 

  34. Burgos, C. M., Frenckner, B. & Broman, L. M. Premature and extracorporeal life support: is it time? A systematic review. ASAIO J. 68, 633–645 (2022).

  35. Balasubramaniam, J. & Del Bigio, M. R. Animal models of germinal matrix hemorrhage. J. Child Neurol. 21, 365–371 (2006).

    Article  PubMed  Google Scholar 

  36. Ting, P., Yamaguchi, S., Bacher, J. D., Killens, R. H. & Myers, R. E. Failure to produce germinal matrix or intraventricular hemorrhage by hypoxia, hypo-, or hypervolemia. Exp. Neurol. 83, 449–460 (1984).

    Article  CAS  PubMed  Google Scholar 

  37. Rambaud, J., Guilbert, J., Guellec, I. & Renolleau, S. A pilot study comparing two polymethylpentene extracorporeal membrane oxygenators. Perfusion 28, 14–20 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Mark Jeakle and Joseph Hill for performing much of the laboratory testing for this manuscript.

Funding

This study was supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD073475; PI: G.B.M.).

Author information

Authors and Affiliations

Authors

Contributions

B.P.F., O.L.-C., T.C.M., and G.L. made substantial contributions to the conception or design of the work; the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agree to be accountable for all aspects of the work. S.L.H., M.W.L., M.D.J., C.S., N.M., and R.R. made substantial contributions to the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agree to be accountable for all aspects of the work. A.R.-P., M.E.M., R.H.B., and G.B.M. made substantial contributions to the conception or design of the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Brian P. Fallon.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fallon, B.P., Lautner-Csorba, O., Major, T.C. et al. Extracorporeal life support without systemic anticoagulation: a nitric oxide-based non-thrombogenic circuit for the artificial placenta in an ovine model. Pediatr Res 95, 93–101 (2024). https://doi.org/10.1038/s41390-023-02605-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41390-023-02605-2

This article is cited by

Search

Quick links